The global allergy diagnostic market size is calculated at USD 6,225 million in 2024 and is predicted to reach around USD 13,193 million by 2034, expanding at a CAGR of 7.8% from 2024 to 2034.
The incidence of allergies, technological developments, and increased patient awareness are some of the reasons driving the steady expansion of the allergy diagnostic market. The growing emphasis on preventive medicine and early disease detection, as well as advantageous government initiatives, support the market expansion for allergy diagnostics.
Advances in biologic medicines aiming certain immune pathways and integrating digital health systems for remote allergy management and tailoring are driving innovation. These advancements are transforming methods for diagnosing and treating allergies.
The increasing demand in North America can be attributed to favorable reimbursement scenarios, increased investment for allergy diagnostic companies to develop new product launches, and a rise in demand for quick diagnostic test kits.
The Asia Pacific is anticipated to develop quickly throughout the projected period due to rising infrastructure and healthcare reforms. The market is growing due to local company entries, rising allergy prevalence, and population growth. India, China, and Japan are also important markets.
Published by Ajit Bansod
